Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,250 across all filing types
Latest filing 2020-02-24 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于员工持股计划方案调整暨大宗交易完成的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 三诺生物传感股份有限公司 regarding adjustments to its employee stock ownership plan and completion of block trades. It details the history, adjustments, and transactions related to the employee stock ownership plan, including share purchases and sales, trust plan changes, and compliance with regulatory requirements. The document is a formal announcement of these changes and transactions rather than a full financial report or detailed management discussion. It does not contain comprehensive financial statements or quarterly/yearly financial results. The document length is 4130 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it relates to changes in share ownership structure and financing activities through employee stock plans and block trades.
2020-02-24 Chinese
关于为子公司提供担保的进展公告
Regulatory Filings Classification · 95% confidence The document is a progress announcement regarding guarantees provided by the company for its subsidiary. It details the guarantee amount, the parties involved, and the status of the guarantee. It references previous board and shareholder meeting approvals but does not contain financial statements or detailed financial results. The document length is short (1960 characters) and it is an announcement of a specific corporate action related to guarantees, not a full financial report or audit. This fits best under Regulatory Filings (RNS) as it is a regulatory announcement about guarantee progress and related contractual details, without being a full report or financial statement.
2020-02-19 Chinese
2019年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2019年度业绩快报' which translates to '2019 Annual Performance Express Report' or '2019 Annual Results Brief'. It contains preliminary financial data for the year 2019, including revenue, profit, net income, and asset figures. The text explicitly states that the data is preliminary, unaudited, and subject to change in the final annual report. It also mentions that the detailed audited financial data will be disclosed in the 2019 Annual Report. The document is relatively short (2565 characters) and serves as an initial earnings announcement rather than a full comprehensive annual report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or annual financial results with key highlights only. It is not the full Annual Report (10-K), nor an Audit Report (AR), nor a Report Publication Announcement (RPA) because it contains substantive preliminary financial data, not just a notice of report availability. Therefore, the correct classification is Earnings Release (ER).
2020-02-14 Chinese
第一期员工持股计划管理办法(三次修订稿)
Governance Information Classification · 95% confidence The document is a detailed management and operational guideline for an employee stock ownership plan (ESOP) of a company, including legal references, participation criteria, management structure, rights and obligations of participants, and procedural rules. It is not a financial report, earnings release, or regulatory announcement. It does not contain financial statements or earnings data, nor is it a notice or announcement of a report. It is a governance-related document detailing internal rules and management of the employee stock ownership plan. Therefore, it fits best under Governance Information (CGR).
2020-02-10 Chinese
独立董事关于公司第四届董事会第二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the company's fourth board meeting, specifically regarding revisions to the company's first employee stock ownership plan. It references compliance with relevant laws and regulations, the board's authorization, and the appropriateness of the plan adjustments. The document is a formal opinion letter from independent directors rather than a full report, financial statement, or announcement of voting results. It does not contain financial data or detailed financial analysis, nor is it a regulatory filing or announcement of a report publication. This fits best under Board/Management Information (MANG), as it relates to board meeting matters and independent directors' opinions on company governance issues.
2020-02-10 Chinese
第一期员工持股计划(三次修订稿)
Capital/Financing Update Classification · 95% confidence The document is titled "三诺生物第一期员工持股计划(三次修订稿)" which translates to "SanNuo Bio First Employee Stock Ownership Plan (Third Revised Draft)". It extensively details the structure, legal basis, funding, stock purchase, management, and operational rules of an employee stock ownership plan (ESOP). It includes information about stock transactions, trust arrangements, lock-up periods, and governance related to the employee stock plan. There is no indication that this is a general annual report, earnings release, or regulatory filing. It is not a proxy solicitation or voting results announcement. The document is a detailed plan and report on the employee stock ownership plan, which is a capital/financing related update about the company's stock ownership structure and employee incentives. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the plan itself, not just an announcement or summary, so it is not RPA or RNS. Confidence is high due to the detailed nature and specific focus on employee stock ownership plan and related financing transactions.
2020-02-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.